Consider These Factors in an Academic Radiation Oncology PositionMarch 14, 2024Aggressive LymphomasALLAMLB Cell LymphomaBusiness of MedicineCLLCML
Look Beyond BMI: Metabolic Factors’ Link to Cancer ExplainedMarch 14, 2024Patient & Survivor CareDLBCLALLAggressive LymphomasAMLB Cell LymphomaCLL
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?March 13, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaBusiness of Medicine
High Marks for New CAR T Toxicity Grading ToolMarch 12, 2024Cellular TherapyB Cell LymphomaDLBCLMantle Cell LymphomaMultiple MyelomaTransplantMixed Topics
FDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineDLBCLAggressive LymphomasALLAML
Are Food Emulsifiers Associated With Increased Cancer Risk?February 23, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Democratic Lawmakers Press Pfizer on Chemotherapy Drug ShortagesFebruary 22, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLBleeding Disorders
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Gene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALLAML
Relapsed DLBCL: With Complete Interim Response, SCT Outperforms CAR TDecember 11, 2023DLBCLTransplantB Cell LymphomaMixed TopicsCellular Therapy
FDA OKs new agent to block chemotherapy-induced neutropeniaNovember 29, 2023Mixed TopicsAggressive LymphomasB Cell LymphomaDLBCLHodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
FDA panel voices concerns over 2 lymphoma accelerated approvalsNovember 17, 2023T Cell LymphomasMixed TopicsALLAggressive LymphomasB Cell LymphomaCLLAML
DLBCL treatment options: CAR T outperforms ASCTNovember 3, 2023DLBCLCellular TherapyTransplantNon-Hodgkin Lymphoma
Safely skip PET2 after brentuximab in Hodgkin lymphoma?September 13, 2023B Cell LymphomaDLBCLAggressive Lymphomas
ESMO helps hematologists assess new cancer drugsJune 28, 2023Mixed TopicsCellular TherapyCMLCLLAggressive LymphomasALLAML
